Google News
logo
Daily Current Affairs
Who has been appointed as the new Drug Controller General of India (DCGI) on 22nd Feb 2023?
A)
John Darkwah
B)
Rajeev Singh Raghuvanshi
C)
Rajeev Kumar Jain
D)
G. Kamala Vardhana Rao

Correct Answer :   Rajeev Singh Raghuvanshi


Rajeev Singh Raghuvanshi has been appointed as the new Drugs Controller General of India (DCGI), Central Drugs Standard Control Organization (CDSCO) by the Appointment Committee of the Cabinet led by the Prime Minister Narendra Modi on Wednesday (22nd Feb 2023).

* Raghuvanshi will be replacing PBN Prasad, who was given an interim charge of DCGI. The Union Health Ministry had appointed P B N Prasad as interim DCGI on February 16 till February 28, 2023.

* Prasad had replaced V G Somani, whose three-year tenure had expired in August 2022. He was, however, not given more extension beyond the two he received in August and November in the year 2022.

* Lately, the Union Government, in an official statement said, “The Appointment Committee of the Cabinet has approved the proposal for appointment of Dr Rajeev Singh Raghuvanshi, Secretary-cum-Scientific Director, Indian Pharmacopoeia Commission to the post of Drugs Controller (India), Central Drugs Standard Control Organization (CDSCO) in level 14 of the Pay Matrix, on short term contract basis, with effect from the date of his assumption of charge of the post till his attainting the age of superannuation on 28.2.2025, or until further orders, whichever is earlier."

* The Union Public Service Commission (UPSC) held interviews for the appointment of the DCGI in January. On 6 February that the UPSC panel had recommended the name of Raghuvanshi for the country’s top drug regulators’ post. The top contenders for the post were Somani himself, Raghuvanshi and Jai Prakash. On January 30, the UPSC communicated its decision to the Health Ministry and recommended Raghuvanshi for the post of the country's apex drug regulator.

* The role of DCGI holds significance as the occupant of the post is the head of CDSCO, which is the agency in charge of ensuring the quality of medicines, new drugs and vaccines, and monitoring related-clinical trials.

* Raghuvanshi, who has worked in various roles at some of India's leading pharmaceutical companies is a Masters from IIT-BHU, and PhD from the National Institute of Immunology, New Delhi...

Source : Medical Dialogues

Published On : February 23, 2023
Advertisement